NYSE to Commence Delisting Proceedings Against Accendra Health, Inc. (ACH)
Accendra Health, Inc. 2026 Q3 - Results - Earnings Call Presentation
Accendra (ACH) Q3 2026 Earnings Call Transcript
Accendra Health Inc (ACH) (Q3 2026) Earnings Call Highlights: Revenue Slips 1% as Guidance Cut ...
Accendra Health, Inc. (ACH) Q3 2026 Earnings Call Transcript
Accendra Health (NYSE:ACH) Q3 2026 Earnings Miss and Lowered Guidance Trigger Selloff
Accendra Health Reports Third Quarter 2026 Financial Results
Accendra Health Q3 2026 Earnings Call Transcript
Accendra Health Affirms FY2026 Sales Guidance of $2.450B-$2.550B vs $2.491B Est
Accendra Health Announces Extension of $150 Million Receivables Sale Program To 2029
Accendra Health Extends $150M Receivables Purchase Agreement To October 2029 With Its Size Unchanged
Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders’ Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard
Accendra Health Consensus Price Target Decreased by 16.53% to $1.29
Accendra Health Announces Third Quarter 2026 Earnings Release Date and Conference Call
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
Accendra Health Form 13G Shows Bank Of America Reports 10.8% Stake In Co. As Of Sept. 30
Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth
Accendra Health Names Kenneth Gardner-Smith as Next President and CEO; Expected To Assume the Role Early in Q4 of 2026, succeeding Edward Pesicka
Accendra Health Appoints Kenneth Gardner-Smith As President And CEO, Succeeding Edward Pesicka
Accendra Health (ACH) Price Target Decreased by 65.60% to 1.54
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.